NFKB1 and neoplasm: All these studies agreed that the activation of ERK, NF-kB and JAK/STAT pathways leads to PD-L1 upregulation, regardless of the tumor sample type (primary vs. metastatic) and of the androgen responsiveness/resistance of the analyzed PC-cell lines.